Skip to content

Drug interactions

Dextromethorphan + Imlunestrant

Severity: Minor

Dextromethorphan and Imlunestrant: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Imlunestrant weakly inhibits CYP2D6, which increases exposure to dextromethorphan, a sensitive CYP2D6 substrate. This may lead to more dextromethorphan-related adverse effects such as dizziness or drowsiness.

What this interaction means in plain words

Dextromethorphan and Imlunestrant have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Dextromethorphan belongs to Respiratory; Imlunestrant belongs to Oncology.

Evidence level: Moderate

Why it happens

CYP2D6 inhibition by imlunestrant reduces dextromethorphan metabolism.

What to do

Monitor for dextromethorphan adverse effects and use the lowest effective dose. Similar caution applies to other CYP2D6 substrates with a narrow therapeutic index.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dextromethorphan and Imlunestrant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dextromethorphan with Imlunestrant?

MediHelp rates the interaction as minor. Dextromethorphan and Imlunestrant have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Imlunestrant weakly inhibits CYP2D6, which increases exposure to dextromethorphan, a sensitive CYP2D6 substrate. This may lead to more dextromethorphan-related adverse effects such as dizziness or drowsiness.

How serious is the interaction between Dextromethorphan and Imlunestrant?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for dextromethorphan adverse effects and use the lowest effective dose. Similar caution applies to other CYP2D6 substrates with a narrow therapeutic index.

What other medicines interact with Imlunestrant?

MediHelp also lists interactions of Imlunestrant with, for example, Carbamazepine, Itraconazole, Digoxin. The full list is on the Imlunestrant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in